Strategic Advocates »

Fs Global Cr Opportunitie Fda shares owned by Strategic Advocates

Quarter-by-quarter ownership of Fs Global Cr Opportunitie Fda (FSCO) shares owned by Strategic Advocates from 13F filings

Historical chart of Strategic Advocates investment in Fs Global Cr Opportunitie Fda

Tip: Access up to 7 years of quarterly data

All positions including Fs Global Cr Opportunitie Fda held by Strategic Advocates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fs Global Cr Opportunitie Fda by Strategic Advocates

Quarter filed Position value Share count Share price at filing
2024-09-30 $210k 33k 6.35
2024-06-30 $211k 33k 6.37
2024-03-31 $196k 33k 5.93
2023-12-31 $209k 37k 5.67

More positions owned by Strategic Advocates

Vanguard Intermediate-term Bond Etf Etf (BIV)
Spdr S&p Kensho New Economies Composite Etf Etf (KOMP)
Invesco Qqq Trust Series I Etf (QQQ)
Invesco S&p 500 Pure Value Etf Etf (RPV)
Spdr Portfolio Long Term Corporate Bond Etf Etf (SPLB)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Vanguard S&p Small-cap 600 Growth Etf Etf (VIOG)
Nvidia Corporation Stock (NVDA)
Pimco 0-5 Year High Yield Corporate Bond Index Exchange-traded Fund Etf (HYS)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Apple Stock (AAPL)
Amazon Stock (AMZN)
Intuitive Surgical Stock (ISRG)
Meta Platforms Inc Cl A Stock (META)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)

View all positions for Strategic Advocates

Top funds holding Fs Global Cr Opportunitie Fda

Commonwealth Equity Services
Cambridge Investment Research Advisors
Nomura Holdings
Thomas J. Herzfeld Advisors
Wagner Wealth Management
Cetera Investment Advisers
LPL Financial
Envestnet Asset Management
H D Vest Advisory Services
Vista Finance
Rockefeller Capital Management
Advisor Group Holdings
Ellis Investment Partners
Private Advisor
Kestra Advisory Services

View all funds holding Fs Global Cr Opportunitie Fda